A Case of Suspected Cardiac Amyloidosis: A Diagnostic Challenge in a 22-Year-Old Male with Restrictive Cardiomyopathy

A Case of Suspected Cardiac Amyloidosis: A Diagnostic Challenge in a 22-Year-Old Male with Restrictive Cardiomyopathy

Authors

  • I Gusti Ayu Aruna Krisnadewani General Practitioner, Intern of Cardiology and Vascular Department, RSUD Kota Mataram, Indonesia
  • Bayu Setia Cardiology and Vascular Department, RSUD Kota Mataram, Indonesia

Keywords:

amyloidosis, cardiac amyloidosis, restrictive cardiomyopathy, heart failure, young adult, NT-proBNP

Abstract

Introduction

Cardiac amyloidosis (CA) is a progressive and often terminal infiltrative cardiomyopathy resulting from the extracellular deposition of misfolded protein fibrils—primarily immunoglobulin light chains (AL) or transthyretin (ATTR)—within the heart muscle. While historically perceived as a rare condition affecting the elderly, advances in non-invasive imaging have revealed CA as an underdiagnosed cause of heart failure. However, its manifestation in young adults remains exceptionally rare, presenting a significant diagnostic challenge for general practitioners. Early recognition is vital, as subtype-specific therapies can significantly alter the clinical trajectory.

Case Illustration

We report the case of a 22-year-old male who presented with a two-week history of progressive dyspnea, orthopnea, abdominal distention, and periorbital edema. Physical examination revealed signs of systemic congestion, including ascites (shifting dullness) and decreased breath sounds in the right lung, alongside a blood pressure of 130/90 mmHg  and a heart rate of 94 bpm . Laboratory findings were remarkable for a severely elevated NT-proBNP of 8177.11 pg/mL  and a high hemoglobin of 18.2 g/dL . Chest radiography demonstrated cardiomegaly (CTR 63%), pulmonary edema, and bilateral pleural effusion. Electrocardiography (ECG) revealed low-voltage QRS complexes, which stood in stark contrast to the echocardiographic evidence of significant ventricular wall thickening (IV S 1.27 cm, LV PW 1.83 cm, ) and a reduced ejection fraction of 35.3% . The discordance between ECG voltage and echocardiographic mass, combined with Grade III diastolic dysfunction, strongly suggested cardiac amyloidosis.

Discussion

The diagnostic hallmark in this case is the "voltage-to-mass" discordance, a pathognomonic red flag where amyloid fibrils insulate the myocardium, dampening electrical signals despite increased wall thickness. In a 22-year-old, the differential diagnosis includes hereditary transthyretin amyloidosis (vATTR) or immunoglobulin light chain (AL) amyloidosis, alongside mimickers like sarcoidosis or Fabry disease. The elevated NT-proBNP and high hemoglobin reflect severe hemodynamic stress and potential hemoconcentration. Management involved stabilizing heart failure using loop diuretics and transitioning to guideline-directed medical therapy (GDMT), while pursuing definitive subtyping through serum/urine immunofixation and cardiac imaging.

Conclusion

This case emphasizes that cardiac amyloidosis must be considered in young patients presenting with unexplained heart failure and restrictive physiology. Maintaining a high index of suspicion for "red flags" like ECG-echo discordance is essential to facilitate early diagnosis and initiation of life-saving, subtype-specific treatments.

References

Cardiac amyloidosis: a case review series - OAText, diakses Februari 20, 2026, https://www.oatext.com/Cardiac-amyloidosis-a-case-review-series.php

Cardiac amyloidosis: epidemiology, diagnosis and therapy, diakses Februari 20, 2026, https://www.escardio.org/communities/councils/cardiology-practice/scientific-documents-and-publications/ejournal/volume-19/cardiac-amyloidosis-epidemiology-diagnosis-and-therapy/

In vitro and in vivo disease models of cardiac amyloidosis: progress, pitfalls, and potential, diakses Februari 20, 2026, https://academic.oup.com/cardiovascres/article/121/13/1997/8245316

Cardiac Amyloidosis: Clinical Features, Pathogenesis, Diagnosis ..., diakses Februari 20, 2026, https://pmc.ncbi.nlm.nih.gov/articles/PMC10823787/

Wild type transthyretin cardiac amyloidosis in a young individual: A case report - PMC, diakses Februari 20, 2026, https://pmc.ncbi.nlm.nih.gov/articles/PMC8084012/

Diagnosing Cardiac Amyloidosis: Challenges and Current Gaps in Detection - Ultromics, diakses Februari 20, 2026, https://www.ultromics.com/articles/diagnosing-cardiac-amyloidosis-challenges-and-gaps-in-detection

Feature | Cardiac Amyloidosis and How to Stop Missing the Diagnosis, diakses Februari 20, 2026, https://www.acc.org/Latest-in-Cardiology/Articles/2024/04/01/00/42/Feature-Cardiac-Amyloidosis-and-How-to-Stop-Missing-the-Diagnosis

ATTR vs AL Amyloidosis - Decision Point - Medscape, diakses Februari 20, 2026, https://decisionpoint.medscape.com/cardiology/viewarticle/1003194

Cardiac Amyloidosis with Discordant QRS Voltage between Frontal ..., diakses Februari 20, 2026, https://pmc.ncbi.nlm.nih.gov/articles/PMC8306315/

Proteotoxicity in cardiac amyloidosis: amyloidogenic light chains affect the levels of intracellular proteins in human heart cells - PMC, diakses Februari 20, 2026, https://pmc.ncbi.nlm.nih.gov/articles/PMC5688098/

Cardiac Amyloidosis Due to Transthyretin Protein: A Review - PMC - NIH, diakses Februari 20, 2026, https://pmc.ncbi.nlm.nih.gov/articles/PMC11167454/

Transthyretin Amyloidosis (ATTR-CM): Types, Causes, Treatment - Cleveland Clinic, diakses Februari 20, 2026, https://my.clevelandclinic.org/health/diseases/17855-amyloidosis-attr

Hereditary ATTR Amyloidosis, diakses Februari 20, 2026, https://arci.org/about-amyloidosis/hereditary-attr-amyloidosis/

Hereditary ATTR Amyloidosis - UCL, diakses Februari 20, 2026, https://www.ucl.ac.uk/medical-sciences/sites/medical_sciences/files/hereditary_attr_amyloidosis.pdf

Redefining the epidemiology of cardiac amyloidosis. A systematic review and meta‐analysis of screening studies - PMC, diakses Februari 20, 2026, https://pmc.ncbi.nlm.nih.gov/articles/PMC10084346/

Restrictive Cardiomyopathy Differential Diagnoses - Medscape Reference, diakses Februari 20, 2026, https://emedicine.medscape.com/article/153062-differential

Amyloidosis: a case series and review of the literature - PMC, diakses Februari 20, 2026, https://pmc.ncbi.nlm.nih.gov/articles/PMC10120233/

Restrictive Cardiomyopathy | Circulation Research - American Heart Association Journals, diakses Februari 20, 2026, https://www.ahajournals.org/doi/10.1161/circresaha.117.310982

AL – Amyloidosis Foundation, diakses Februari 20, 2026, https://amyloidosis.org/al/

Hereditary Transthyretin Amyloidosis - GeneReviews® - NCBI Bookshelf - NIH, diakses Februari 20, 2026, https://www.ncbi.nlm.nih.gov/books/NBK1194/

Amyloidosis - NHS, diakses Februari 20, 2026, https://www.nhs.uk/conditions/amyloidosis/

AL Amyloidosis, diakses Februari 20, 2026, https://arci.org/about-amyloidosis/al-amyloidosis/

Immunoglobulin light chain amyloidosis: 2024 update on diagnosis, prognosis, and treatment - PubMed, diakses Februari 20, 2026, https://pubmed.ncbi.nlm.nih.gov/38095141/

New Treatments for Cardiac Amyloidosis Emerging, but Timely Diagnosis Remains Essential to Improving Outcomes - AdventHealth, diakses Februari 20, 2026, https://www.adventhealth.com/medical/adventhealthmd/blog/new-treatments-cardiac-amyloidosis-emerging-timely-diagnosis-remains-essential-improving-outcomes

Cardiac Amyloidosis: A Hidden Cause of Heart Failure Is Now Treatable, diakses Februari 20, 2026, https://www.uhhospitals.org/blog/articles/2025/11/cardiac-amyloidosis

Palladini G, Milani P. Diagnosis and Treatment of AL Amyloidosis. Drugs. 2023 Feb;83(3):203-216. doi: 10.1007/s40265-022-01830-z. Epub 2023 Jan 18. PMID: 36652193. https://pubmed.ncbi.nlm.nih.gov/36652193/

Amyloidosis - Symptoms and causes - Mayo Clinic, diakses Februari 20, 2026, https://www.mayoclinic.org/diseases-conditions/amyloidosis/symptoms-causes/syc-20353178

AL Amyloidosis (Primary Amyloidosis): Symptoms, Treatment & What it Is - Cleveland Clinic, diakses Februari 20, 2026, https://my.clevelandclinic.org/health/diseases/15718-amyloidosis-al-amyloid-light-chain

Cardiac amyloidosis: Innovations in diagnosis and treatment ..., diakses Februari 20, 2026, https://academic.oup.com/eurheartjsupp/article/27/Supplement_1/i88/8023290

New Validated Staging System for Light Chain (AL) Amyloidosis With Stage IIIC Defining Ultra-Poor Risk - ASCO Publications, diakses Februari 20, 2026, https://ascopubs.org/doi/10.1200/JCO-25-02558

High hemoglobin count Causes - Mayo Clinic, diakses Februari 20, 2026, https://www.mayoclinic.org/symptoms/high-hemoglobin-count/basics/causes/sym-20050862

High Hemoglobin Count: Causes, Testing & Treatment - Cleveland Clinic, diakses Februari 20, 2026, https://my.clevelandclinic.org/health/symptoms/17789-high-hemoglobin-count

Electrocardiographic Patterns and Arrhythmias in Cardiac Amyloidosis: From Diagnosis to Therapeutic Management—A Narrative Review - MDPI, diakses Februari 20, 2026, https://www.mdpi.com/2077-0383/13/18/5588

Why do patients with cardiac amyloidosis often have low voltage QRS (electrocardiogram) complexes? - Dr.Oracle, diakses Februari 20, 2026, https://www.droracle.ai/articles/738913/why-do-patients-with-cardiac-amyloidosis-often-have-low

What Cardiologists Should Know About Amyloidosis - PMC, diakses Februari 20, 2026, https://pmc.ncbi.nlm.nih.gov/articles/PMC12471172/

ECG/echo indexes in the diagnostic approach to amyloid cardiomyopathy: A head-to-head comparison from the AC - ArTS, diakses Februari 20, 2026, https://arts.units.it/retrieve/21eedcfe-931f-48c2-97ad-9d626ff8c837/1-s2.0-S0953620523003461-main-Post_print.pdf

Heart Failure Management in Cardiac Amyloidosis: Towards a Paradigm Shift - PMC, diakses Februari 20, 2026, https://pmc.ncbi.nlm.nih.gov/articles/PMC12308146/

Meta-Analysis of Pharmacological Treatments in HFmrEF and HFpEF - ACC.org, diakses Februari 20, 2026, https://www.acc.org/Latest-in-Cardiology/Journal-Scans/2024/04/02/13/07/pharmacological-treatments-in-heart

Cardiac amyloidosis: A case report and review of literature - Baishideng Publishing Group, diakses Februari 20, 2026, https://www.wjgnet.com/2307-8960/full/v7/i6/742

Proteotoxicity and Cardiac Dysfunction - PMC - NIH, diakses Februari 20, 2026, https://pmc.ncbi.nlm.nih.gov/articles/PMC4443853/

Hereditary transthyretin amyloidosis: a comprehensive review with a focus on peripheral neuropathy - PMC, diakses Februari 20, 2026, https://pmc.ncbi.nlm.nih.gov/articles/PMC10585157/

Restrictive cardiomyopathy - EPOS™, diakses Februari 20, 2026, https://epos.myesr.org/poster/esr/ecr2020/C-10216/findings%20and%20procedure%20details

Molecular Mechanisms of Cardiac Amyloidosis - PMC, diakses Februari 20, 2026, https://pmc.ncbi.nlm.nih.gov/articles/PMC8744761/

AL Amyloidosis Patients Continue to Benefit from HDCT/ASCT Consolidation in the Daratumumab Era - MDPI, diakses Februari 20, 2026, https://www.mdpi.com/2077-0383/15/4/1564

Cardiac Amyloidosis Echocardiographic Appearance - Brigham and Women's Hospital, diakses Februari 20, 2026, https://www.brighamandwomens.org/heart-and-vascular-center/procedures/cardiac-amyloidosis-echocardiographic-appearance

Diagnostic challenges in cardiac amyloidosis: a case report of negative initial endomyocardial biopsy, diakses Februari 20, 2026, https://e-century.us/files/ijppp/17/3/ijppp0164514.pdf

Restrictive Cardiomyopathy - StatPearls - NCBI Bookshelf - NIH, diakses Februari 20, 2026, https://www.ncbi.nlm.nih.gov/books/NBK537234/

2024 AHA/ACC/AMSSM/HRS/PACES/SCMR Guideline for the Management of Hypertrophic Cardiomyopathy, diakses Februari 20, 2026, https://www.ahajournals.org/doi/10.1161/CIR.0000000000001250

Restrictive cardiomyopathy: definition and diagnosis - SciSpace, diakses Februari 20, 2026, https://scispace.com/pdf/restrictive-cardiomyopathy-definition-and-diagnosis-3pcra7fm.pdf

Restrictive Cardiomyopathy (RCM) - DynaMedex, diakses Februari 20, 2026, https://www.dynamedex.com/condition/restrictive-cardiomyopathy-rcm

Restrictive cardiomyopathy: definition and diagnosis - PMC, diakses Februari 20, 2026, https://pmc.ncbi.nlm.nih.gov/articles/PMC9712030/

Incidence and effect of secondary cardiac amyloidosis on outcomes of patients with t(11;14) multiple myeloma - PMC, diakses Februari 20, 2026, https://pmc.ncbi.nlm.nih.gov/articles/PMC9479066/

Vitamin A: What you should know about supplements and ATTR-CM treatments, diakses Februari 20, 2026, https://mcpress.mayoclinic.org/attr-cm/vitamin-a-what-you-should-know-about-supplements-and-attr-cm-treatments/

Cardiac Amyloidosis: Evolving Diagnosis and Management: A ..., diakses Februari 20, 2026, https://www.hfsa.org/cardiac-amyloidosis-evolving-diagnosis-and-management-scientific-statement-american-heart

Cardiac amyloidosis: Innovations in diagnosis and treatment - PMC, diakses Februari 20, 2026, https://pmc.ncbi.nlm.nih.gov/articles/PMC11836727/

AL or ATTR Amyloidosis? Never Two Without Three | Circulation, diakses Februari 20, 2026, https://www.ahajournals.org/doi/10.1161/CIRCULATIONAHA.124.072460

Cardiac Amyloidosis - European Society of Cardiology, diakses Februari 20, 2026, https://www.escardio.org/education/content-collections/focus/cardiac-amyloidosis/

Heart Failure Management in Cardiac Amyloidosis: Towards a Paradigm Shift, diakses Februari 20, 2026, https://www.researchgate.net/publication/394102459_Heart_Failure_Management_in_Cardiac_Amyloidosis_Towards_a_Paradigm_Shift

2024 update in heart failure - PubMed, diakses Februari 20, 2026, https://pubmed.ncbi.nlm.nih.gov/38806171/

2024 Update to the 2020 ACC/AHA Clinical Performance and Quality Measures for Adults With Heart Failure - ISHLT.org, diakses Februari 20, 2026, https://www.ishlt.org/docs/default-source/standards-guidelines/2024_endorsement_acc_aha_hfqualitymeasures.pdf?sfvrsn=46e21716_1

Diastolic Dysfunction Unveiling Cardiac Light-Chain Amyloidosis: A Case Report, diakses Februari 20, 2026, https://esmed.org/MRA/mra/article/view/6168

Defining a New “Mayo Stage IIIc” Ultra Poor Risk Category in Systemic AL Amyloidosis, diakses Februari 20, 2026, https://ashpublications.org/blood/article/144/Supplement%201/890/530852/Defining-a-New-Mayo-Stage-IIIc-Ultra-Poor-Risk

Downloads

Published

2026-02-22

How to Cite

I Gusti Ayu Aruna Krisnadewani, and Bayu Setia. 2026. “A Case of Suspected Cardiac Amyloidosis: A Diagnostic Challenge in a 22-Year-Old Male With Restrictive Cardiomyopathy”. The International Journal of Medical Science and Health Research 32 (2): 137-62. https://doi.org/10.70070/hrdsjh73.